GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (MIL:1EW) » Definitions » Cyclically Adjusted FCF per Share

Edwards Lifesciences (MIL:1EW) Cyclically Adjusted FCF per Share : €1.30 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Edwards Lifesciences's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.211. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €1.30 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Edwards Lifesciences's average Cyclically Adjusted FCF Growth Rate was 0.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 16.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 18.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Edwards Lifesciences was 26.00% per year. The lowest was 11.20% per year. And the median was 17.20% per year.

As of today (2024-06-01), Edwards Lifesciences's current stock price is €79.92. Edwards Lifesciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €1.30. Edwards Lifesciences's Cyclically Adjusted Price-to-FCF of today is 61.48.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Edwards Lifesciences was 113.15. The lowest was 36.33. And the median was 69.21.


Edwards Lifesciences Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted FCF per Share Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.37

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.37 1.30

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted Price-to-FCF falls into.



Edwards Lifesciences Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Edwards Lifesciences's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.211/131.7762*131.7762
=-0.211

Current CPI (Mar. 2024) = 131.7762.

Edwards Lifesciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.870 100.560 1.140
201409 -0.007 100.428 -0.009
201412 0.059 99.070 0.078
201503 0.073 99.621 0.097
201506 0.205 100.684 0.268
201509 0.238 100.392 0.312
201512 0.087 99.792 0.115
201603 0.109 100.470 0.143
201606 0.153 101.688 0.198
201609 0.215 101.861 0.278
201612 0.200 101.863 0.259
201703 0.158 102.862 0.202
201706 0.187 103.349 0.238
201709 0.356 104.136 0.450
201712 0.398 104.011 0.504
201803 0.132 105.290 0.165
201806 0.117 106.317 0.145
201809 0.345 106.507 0.427
201812 0.325 105.998 0.404
201903 -0.080 107.251 -0.098
201906 0.375 108.070 0.457
201909 0.515 108.329 0.626
201912 0.468 108.420 0.569
202003 0.178 108.902 0.215
202006 0.176 108.767 0.213
202009 0.152 109.815 0.182
202012 0.367 109.897 0.440
202103 0.259 111.754 0.305
202106 0.602 114.631 0.692
202109 0.634 115.734 0.722
202112 0.392 117.630 0.439
202203 0.318 121.301 0.345
202206 0.436 125.017 0.460
202209 0.404 125.227 0.425
202212 0.297 125.222 0.313
202303 0.366 127.348 0.379
202306 -0.002 128.729 -0.002
202309 0.548 129.860 0.556
202312 0.053 129.419 0.054
202403 -0.211 131.776 -0.211

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Edwards Lifesciences  (MIL:1EW) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Edwards Lifesciences's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=79.92/1.3
=61.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Edwards Lifesciences was 113.15. The lowest was 36.33. And the median was 69.21.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Edwards Lifesciences Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (MIL:1EW) Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (MIL:1EW) Headlines

No Headlines